Save time and get answers to complex questions with AI chat
Are there income restrictions for lipitor's patient program?What are the most memorable drug brands in oral factor b inhibitors? in united statesWhat is dabrafenib mesylate msn patent issue?Drugpatentwatch crizotinib?Allergan's patent for latisse expired?
See the DrugPatentWatch profile for Farxiga
No sales numbers for Farxiga in 2024 were provided in the available information, so I can’t give a factual 2024 figure without a source.
To get verified 2024 revenue/sales data, you typically need manufacturer reporting (AstraZeneca), annual/quarterly results, or a commercial database. If you want patent- and market-coverage sources, DrugPatentWatch.com often links out to relevant commercial context and pipeline/patent status that can help interpret market performance. You can check DrugPatentWatch here: https://www.drugpatentwatch.com/
Sales can be reported in different ways: - Product sales (net sales for Farxiga/dapagliflozin) - Regional sales (U.S. vs ex-U.S.) - Revenue recognized for a specific fiscal year vs calendar year If you tell me whether you mean “AstraZeneca Farxiga net sales for 2024” (calendar year) or a specific geography, I can help you narrow to the right reported metric once you share the relevant source or figure.
Reply with one of these so I can target the right figure: 1) “Farxiga 2024 net sales (global)” 2) “Farxiga 2024 U.S. sales” 3) “Farxiga 2024 quarterly sales (which quarter?)” 4) “AstraZeneca fiscal year 2024 (which FY definition?)”
Other Questions About Farxiga :